Veradermics Inc (MANE)

$37.16 -0.59 (-1.56%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 934,600
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA...

Industry: Biotechnology
Sector: Healthcare
Phone: (228) 372-3376
Address:
470 James Street, Suite 14, New Haven, United States
_sansan_
_sansan_ Apr. 10 at 4:04 PM
$MANE this is the man homie
0 · Reply
flam70
flam70 Apr. 7 at 5:37 PM
$ABSI $MANE mane has 2.3b market cap. Absci 450m
0 · Reply
SagaSeeker
SagaSeeker Apr. 3 at 12:05 AM
$MANE been here for a while trying to get out but need like 50% more lol
0 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Apr. 2 at 2:19 AM
$MANE what's up here?
0 · Reply
zerogray30
zerogray30 Apr. 1 at 5:35 PM
$MANE heard the ceo this morning explain why their hairloss treatment will be better than others options, still in clinical trials I think but this has potential to be the best choice on the market
0 · Reply
HatchersHardSkills
HatchersHardSkills Mar. 25 at 7:27 AM
$MANE looking for the next mane? 👀 https://youtu.be/wKcLMhUhRdw
0 · Reply
rokilitza1977
rokilitza1977 Mar. 23 at 8:18 PM
$MANE what is the float of this one??? on fin viz it said its 26.84 mil. on yahoo it said its 408.74k. which one is correct???
0 · Reply
Culby
Culby Mar. 17 at 6:17 PM
$MANE apparently all this does is go up??
0 · Reply
IN0V8
IN0V8 Mar. 3 at 6:39 PM
$MANE 3/2 Buy Citigroup initiates coverage with buy ?rating; target price $85 Jefferies initiates coverage with buy rating; target price $75 Leerink Partners initiates coverage with outperform rating Leerink Partners initiates coverage with target price $75
0 · Reply
erevnon
erevnon Mar. 2 at 3:57 PM
Citigroup initiates coverage on Veradermics $MANE at Buy rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Latest News on MANE
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates

Mar 30, 2026, 7:30 AM EDT - 12 days ago

Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates

Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting

Mar 18, 2026, 7:00 AM EDT - 24 days ago

Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting

Veradermics to Participate in Upcoming March Investor Conferences

Mar 3, 2026, 7:00 AM EST - 5 weeks ago

Veradermics to Participate in Upcoming March Investor Conferences

NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell

Feb 12, 2026, 8:55 AM EST - 2 months ago

NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell

FPS

Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss

Feb 9, 2026, 7:30 AM EST - 2 months ago

Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss

Veradermics Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

Feb 5, 2026, 4:05 PM EST - 2 months ago

Veradermics Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

Veradermics Announces Pricing of Upsized Initial Public Offering

Feb 3, 2026, 9:57 PM EST - 2 months ago

Veradermics Announces Pricing of Upsized Initial Public Offering

Veradermics, Dermatology Biopharma Focused on Hair Loss, Files for NYSE IPO

Jan 9, 2026, 5:08 PM EST - 3 months ago

Veradermics, Dermatology Biopharma Focused on Hair Loss, Files for NYSE IPO

Veradermics IPO Registration Document (S-1)

Jan 9, 2026, 5:04 PM EST - 3 months ago

Veradermics IPO Registration Document (S-1)

Hair loss biotech Veradermics files for a $100 million IPO

Jan 9, 2026, 3:13 PM EST - 3 months ago

Hair loss biotech Veradermics files for a $100 million IPO

_sansan_
_sansan_ Apr. 10 at 4:04 PM
$MANE this is the man homie
0 · Reply
flam70
flam70 Apr. 7 at 5:37 PM
$ABSI $MANE mane has 2.3b market cap. Absci 450m
0 · Reply
SagaSeeker
SagaSeeker Apr. 3 at 12:05 AM
$MANE been here for a while trying to get out but need like 50% more lol
0 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Apr. 2 at 2:19 AM
$MANE what's up here?
0 · Reply
zerogray30
zerogray30 Apr. 1 at 5:35 PM
$MANE heard the ceo this morning explain why their hairloss treatment will be better than others options, still in clinical trials I think but this has potential to be the best choice on the market
0 · Reply
HatchersHardSkills
HatchersHardSkills Mar. 25 at 7:27 AM
$MANE looking for the next mane? 👀 https://youtu.be/wKcLMhUhRdw
0 · Reply
rokilitza1977
rokilitza1977 Mar. 23 at 8:18 PM
$MANE what is the float of this one??? on fin viz it said its 26.84 mil. on yahoo it said its 408.74k. which one is correct???
0 · Reply
Culby
Culby Mar. 17 at 6:17 PM
$MANE apparently all this does is go up??
0 · Reply
IN0V8
IN0V8 Mar. 3 at 6:39 PM
$MANE 3/2 Buy Citigroup initiates coverage with buy ?rating; target price $85 Jefferies initiates coverage with buy rating; target price $75 Leerink Partners initiates coverage with outperform rating Leerink Partners initiates coverage with target price $75
0 · Reply
erevnon
erevnon Mar. 2 at 3:57 PM
Citigroup initiates coverage on Veradermics $MANE at Buy rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
xelaxela
xelaxela Feb. 19 at 11:52 PM
$MANE Seems like nobody is trading this thing
0 · Reply
THSSKS
THSSKS Feb. 8 at 5:20 PM
$MANE massively underfunded and overvalued bioturd, but huge tam for mpb. Company is essentially broke, if investment bankers push it up for an offering, I’ll be shorting the hell outta this time released rogaine stock.
1 · Reply
Pranee2023
Pranee2023 Feb. 6 at 7:28 PM
$MANE oral minoxidil.
0 · Reply
JayBullsEye
JayBullsEye Feb. 5 at 2:14 PM
$MANE
0 · Reply
VinnyVelvet
VinnyVelvet Feb. 5 at 5:43 AM
$MANE How we feeling about his today?
0 · Reply